Modelling survival and factors associated with HIV-infected and -uninfected patients of prostate cancer at the University Teaching Hospital, Lusaka, Zambia

References

• Adeloye, D., David, R. A., Aderemi, A. V., Iseolorunkanmi, A., Oyedokun, A., Iweala, E. E., & Ayo, C. K. (2016). An estimate of the incidence of prostate cancer in Africa: A systematic review and meta-analysis. PloS One, 11(4), e0153496. https://doi.org/10.1371/journal.pone.0153496
   PubMed Web of Science ®Google Scholar
• Bedimo, R. J., McGinnis, K. A., Dunlap, M., Rodriguez-Barradas, M. C., & Justice, A. C. (2009). Incidence of non-AIDS-defining malignancies in HIV-infected vs. non-infected patients in the HAART era: Impact of immunosuppression. Journal of Acquired Immune Deficiency Syndromes, 52(2), 203. https://doi.org/10.1097/QAI.0b013e3181b033ab
   PubMed Web of Science ®Google Scholar
• Bhindi, B., Mamdani, M., Kulkarni, G. S., Finelli, A., Hamilton, R. J., Trachtenberg, J., Zlotta, A.R., Evans, A., van der Kwast, T.H., Fleshner, N.E., & Toi, A. (2015). Impact of the US preventive services task force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates. The Journal of Urology, 193(5), 1519–13. https://doi.org/10.1016/j.juro.2014.11.096
   PubMed Web of Science ®Google Scholar
• Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Cheng, L., Zincke, H., Blute, M. L., Bergstralh, E. J., Scherer, B., & Bostwick, D. G. (2001). Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer, 91(1), 66–73. doi:10.1002/1097-0142(20010101)91:1<66:AID-CNCR9>3.0.CO;2-P
   PubMed Web of Science ®Google Scholar
• Chiu, B. C.-H., & Weisenburger, D. D. (2003). An update of the epidemiology of non-Hodgkin’s lymphoma. Clinical Lymphoma, 4(3), 161–168. https://doi.org/10.3816/CLM.2003.n.025
   PubMedGoogle Scholar
• Coghill, A. E., Pfeiffer, R. M., Shiels, M. S., & Engels, E. A. (2017). Excess mortality among HIV-infected individuals with cancer in the United States. Cancer Epidemiology and Prevention Biomarkers, 26(7), 1027–1033. https://doi.org/10.1158/1055-9965.EPI-16-0964
   PubMed Web of Science ®Google Scholar
• Facciolà, A., Ceccarelli, M., Rullo, E. V., d’Aleo, F., Condorelli, F., Visalli, G., & Nunnari, G. (2018). Prostate cancer in HIV-positive patients: A review of the literature. AIDS (PLWHA), 51, 54. https://doi.org/10.32113/wcrj_20189_1136
   Google Scholar
• Galego, P., Silva, F. C., & Pinheiro, L. C. (2015). Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence? International Braz J Urol, 41(2), 353–359. https://doi.org/10.1590/S1677-5538.IBJU.2015.02.24
   PubMed Web of Science ®Google Scholar
• Heidenreich, A. (2012). Management of prostate cancer: EAU guidelines on screening, diagnosis and treatment. Management of Prostate Cancer. Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-27597-5_22
   Google Scholar
• Hentrich, M., & Pfister, D. (2017). HIV-associated urogenital malignancies. Oncology Research and Treatment, 40(3), 106–112. https://doi.org/10.1159/000457130
   PubMed Web of Science ®Google Scholar
• Izadmehr, S., Leapman, M., Hobbs, A. R., Katsigeorgis, M., Nabizada-Pace, F., Jazayeri, S. B., & Samadi, D. B. (2016). Clinical characteristics and outcomes of HIV-seropositive men treated with surgery for prostate cancer. International Urology and Nephrology, 48(10), 1639–1645. https://doi.org/10.1007/s11255-016-1338-4
   PubMed Web of Science ®Google Scholar
• Kahn, S., Jani, A., Edelman, S., Rossi, P., Godette, K., Landry, J., & Anderson, C. (2012). Matched cohort analysis of outcomes of definitive radiotherapy for prostate cancer in human immunodeficiency virus-positive patients. International Journal of Radiation Oncology* Biology* Physics, 83(1), 16–21. https://doi.org/10.1016/j.ijrobp.2011.05.047
   PubMed Web of Science ®Google Scholar
• Kalubula, M., Shen, H., Makasa, M., & Liu, L. (2018). Epidemiology of cancers in Zambia: A significant variation in cancer incidence and prevalence across the nation. bioRxiv [Internet], 402628. PMID: 35233276; PMCID: PMC8843183. https://doi.org/10.4314/mmj.v33i3.6
   Google Scholar
• Kenward, M. G., & Carpenter, J. (2007). Multiple imputation: Current perspectives. Statistical Methods in Medical Research, 16(3), 199–218. http://dx.doi.org/10.1177/0962280206075304PMID:17621468
   PubMed Web of Science ®Google Scholar
• Kimani, F. (2012). Cervical, breast and prostate cancers are a major public health concern in Kenya. They are however easily prevented and controlled through behaviour change, vaccination, screening, early detection and treatment of pre-cancerous lesions and/or at early stage disease thereby leading to better management and outcomes for these diseases.
   Google Scholar
• Lilleby, W. (2013). Overall-and disease-specific survival in prostata cancer: Too long to wait? In Radiotherapy in prostate cancer (pp. 65–73). Springer. https://doi.org/10.1007/174_2013_941
   Google Scholar
• Little, R. J., & Rubin, D. B. (2014). Statistical analysis with missing data. John Wiley & Sons.
   Google Scholar
• MacKintosh, F. R., Sprenkle, P. C., Walter, L. C., Rawson, L., Karnes, R. J., Morrell, C. H., Kattan, M.W., Nawaf, C.B., & Neville, T. B. (2016). Age and prostate-specific antigen level prior to diagnosis predict risk of death from prostate cancer. Frontiers in Oncology, 6, 157. https://doi.org/10.3389/fonc.2016.00157
   PubMed Web of Science ®Google Scholar
• Mani, D., & Aboulafia, D. M. (2013). Screening guidelines for non-AIDS defining cancers in HIV-infected individuals. Current Opinion in Oncology, 25(5), 518. https://doi.org/10.1097/CCO.0b013e328363e04a
   PubMed Web of Science ®Google Scholar
• Marcus, J. L., Chao, C. R., Leyden, W. A., Xu, L., Klein, D. B., Horberg, M. A., Towner, W.J., Quesenberry, C.P., Abrams, D.I., Silverberg, M.J., & Van Den Eeden, S. K. (2014). Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. JAIDS Journal of Acquired Immune Deficiency Syndromes, 66(5), 495–502. https://doi.org/10.1097/QAI.0000000000000202
   PubMed Web of Science ®Google Scholar
• Marcus, J. L., Chao, C., Leyden, W. A., Xu, L., Yu, J., Horberg, M. A., Klein, D., Towner, W.J., Quesenberry, C.P., Silverberg, M.J., & Abrams, D. I. (2015). Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiology and Prevention Biomarkers, 24(8), 1167–1173. https://doi.org/10.1158/1055-9965.EPI-14-1079
   PubMed Web of Science ®Google Scholar
• Miyoshi, Y., Noguchi, K., Yanagisawa, M., Taguri, M., Morita, S., Ikeda, I., Fujinami, K., Miura, T., Kobayashi, K., & Uemura, H. (2015). Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer. BMC Cancer, 15(1), 338. https://doi.org/10.1186/s12885-015-1330-x
   PubMedGoogle Scholar
• Montironi, R., Mazzucchelli, R., Scarpelli, M., Lopez‐Beltran, A., Mikuz, G., Algaba, F., & Boccon‐Gibod, L. (2006). Prostate carcinoma II: Prognostic factors in prostate needle biopsies. BJU International, 97(3), 492–497. https://doi.org/10.1111/j.1464-410X.2006.05973.x
   PubMed Web of Science ®Google Scholar
• Organization, W. HWorld Health Organization. (2014). World health rankings: Live longer live better. WHO.
   Google Scholar
• Sterne, J. A., White, I. R., Carlin, J. B., Spratt, M., Royston, P., Kenward, M. G., Wood, A. M., & Carpenter, J. R. (2009). Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ, 338(jun29 1), b2393. http://dx.doi.org/10.1136/bmj.b2393PMID:19564179
   PubMedGoogle Scholar
• Tindall, E. A., Monare, L. R., Petersen, D. C., Van Zyl, S., Hardie, R. A., Segone, A. M., Venter, P.A., Bornman, M.R., & Hayes, V. M. (2014). Clinical presentation of prostate cancer in black South Africans. The Prostate, 74(8), 880–891. https://doi.org/10.1002/pros.22806
   PubMed Web of Science ®Google Scholar
• Von Hippel, P. T. (2009). 8. How to Impute interactions, squares, and other transformed variables. Sociological Methodology, 39(1), 265–291. http://dx.doi.org/10.1111/j.1467-9531.2009.01215.x
   Web of Science ®Google Scholar
• White, I. R., Royston, P., & Wood, A. M. (2011). Multiple imputation using chained equations: Issues and guidance for practice. Statistics in Medicine, 30(4), [23] 377–399. https://doi.org/10.1002/sim.4067
   PubMed Web of Science ®Google Scholar
• Widmark, A., Klepp, O., Solberg, A., Damber, J.-E., Angelsen, A., Fransson, P., Lund, J.Å., Tasdemir, I., Hoyer, M., Fosså, S.D., & Wiklund, J.-Å. (2009). Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial. The Lancet, 373(9660), 301–308. https://doi.org/10.1016/S0140-6736(08)61815-2
   PubMed Web of Science ®Google Scholar
• Winter, A., Sirri, E., Jansen, L., Wawroschek, F., Kieschke, J., Castro, F. A., Holleczek, B., Emrich, K., Waldmann, A., Brenner, H., & Krilaviciute, A. (2017). Comparison of prostate cancer survival in Germany and the USA: Can differences be attributed to differences in stage distributions? BJU International, 119(4), 550–559. https://doi.org/10.1111/bju.13537
   PubMed Web of Science ®Google Scholar
• Yahaya, J. J., Okecha, T., Odida, M., & Wabinga, H. (2020). Prognostic factors for overall survival of patients with prostate cancer in Kyadondo County, Uganda. Prostate Cancer, 2020. https://doi.org/10.1155/2020/8517130
   PubMed Web of Science ®Google Scholar
• Zyaambo, C., Nzala, S. H., Babaniyi, O., Songolo, P., Funkhouser, E., & Siziya, S. (2013). Distribution of cancers in Zambia: Evidence from the Zambia National Cancer Registry (1990–2009). Journal of Public Health and Epidemiology, 5(2), 95–100.
   Google Scholar